Wilmington Healthcare appoints new consultants
October 17, 2019 |
Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has expanded its team with the appointment of two new senior consultants – Roger Tomlins and Sarah Shield.
Wilmington Healthcare appoints new consultants
Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has expanded its team with the appointment of two new senior consultants – Roger Tomlins and Sarah Shield.
In their new roles, Roger and Sarah will help healthcare business leaders to better understand the NHS’s evolving needs and work in strategic partnership with it, as it continues to implement the Long-term Plan and the delivery of sustainable, high value healthcare.
Roger has worked in healthcare for over 16 years, in both the pharmaceutical industry and the NHS. He has joined Wilmington Healthcare from Bristol-Myers Squibb, where he was Senior Regional Access Manager and led new customer- focused initiatives for the company in cardiology and oncology.
Prior to that, he worked for Pfizer Essential Health as a Clinical Effectiveness Consultant. His NHS experience includes working for the Royal Berkshire NHS Foundation Trust as General/Operations Manager for four years, where he led key hospital directorates, including surgery and medicine.
Sarah has worked in the pharmaceutical industry for 14 years and has wide experience of providing consultancy on market access, strategic partnerships, clinical policy development and government affairs.
Before joining Wilmington Healthcare, Sarah was National Policy and Partnership Lead for AstraZeneca UK’s cardiovascular and renal franchise, and provided strategic insight on NHS policies, commissioning and reimbursement pathways.
Other posts that Sarah has held at AstraZeneca, include National NHS Relations Lead, Cardiovascular & Oncology. Prior to that, she worked for GlaxoSmithKline for four years in roles that included Therapy Specialist for its allergy portfolio.
Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Having worked in diverse roles within the healthcare sector, Roger and Sarah bring a wealth of knowledge and experience to their new posts.
“They are perfectly placed to help our clients keep pace with the scale and speed of change within the NHS and create compelling propositions. They will be a great asset to our consultancy team, and we’re delighted to be working with them.”
Ends
Notes to Editors
For more information, please contact: Andrew Baud and Catherine McNulty, Tala, +44 (0) 20 3397 3383 or +44 (0) 7775 715775, Email: andrew.baud@teamtala.com /catherine.mcnulty@teamtala.com
About Wilmington Healthcare and Wilmington plc
Wilmington Healthcare within the UK, incorporates HSJ, Interactive Medica and OnMedica. A part of Wilmington plc whose group companies help clients turn data into actionable business benefit, Wilmington Healthcare focuses on working with its customers to turn its high quality healthcare data into meaningful intelligence to support their business objectives and the improvement of healthcare. For further information, visit www.wilmingtonhealthcare.com.
Wilmington plc focuses on three key knowledge areas: Risk & Compliance, Professional, and Healthcare. Wilmington’s businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and networking. For more information on Wilmington plc visit www.wilmingtonplc.com.
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
Wilmington Healthcare launches new platform to map the formulary landscape
Healthcare intelligence provider Wilmington Healthcare has launched a new platform that enables pharma companies to develop a clear picture of formulary status across therapy areas and territories in the UK.
Wilmington Healthcare appoints new Head of Digital
Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital.In his new role,...
How has the pandemic reshaped the NHS in 2020?
Oli Hudson, of Wilmington Healthcare, explores the major changes that have occurred across the NHS as key aspects of the Long Term Plan are rolled out at speed.
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset
How can pharma align its brand strategy with the NHS Reset?
Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era
Covid-19 redefines rules of customer engagement
Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs
White paper helps industry navigate new NHS roadmap
New report shows how pharma can support the NHS in the Covid-19 recovery era
Covid-19 drives change in long-term conditions management
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home
Covid-19: how is it impacting on the NHS Long-term Plan?
Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it